$IDPH Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOGEN INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in BIOGEN INC.. Get notifications about new insider transactions in BIOGEN INC. for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 10 ... 34 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17 2016 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | M | 0.00 | 1,052 | 0 | 3,842 | |
| Feb 17 2016 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Payment of Exercise | F | 247.22 | 1,204 | 297,653 | 26,564 | 27.8 K to 26.6 K (-4.34 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Buy | M | 0.00 | 2,807 | 0 | 27,768 | 25 K to 27.8 K (+11.25 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Payment of Exercise | F | 247.22 | 495 | 122,374 | 24,961 | 25.5 K to 25 K (-1.94 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Buy | M | 0.00 | 1,052 | 0 | 25,456 | 24.4 K to 25.5 K (+4.31 %) |
| Feb 10 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Option Exercise | M | 0.00 | 11,274 | 0 | 0 | |
| Feb 10 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Payment of Exercise | F | 249.99 | 5,305 | 1,326,197 | 47,059 | 52.4 K to 47.1 K (-10.13 %) |
| Feb 10 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Buy | M | 0.00 | 11,274 | 0 | 52,364 | 41.1 K to 52.4 K (+27.44 %) |
| Feb 10 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | M | 0.00 | 1,278 | 0 | 0 | |
| Feb 10 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Sell | S | 246.54 | 852 | 210,052 | 7,740 | 8.6 K to 7.7 K (-9.92 %) |
| Feb 10 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Payment of Exercise | F | 250.77 | 426 | 106,828 | 8,592 | 9 K to 8.6 K (-4.72 %) |
| Feb 10 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Buy | M | 0.00 | 1,278 | 0 | 9,018 | 7.7 K to 9 K (+16.51 %) |
| Feb 09 2016 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Option Exercise | M | 0.00 | 2,498 | 0 | 0 | |
| Feb 09 2016 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Payment of Exercise | F | 250.77 | 822 | 206,133 | 29,543 | 30.4 K to 29.5 K (-2.71 %) |
| Feb 09 2016 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Buy | M | 0.00 | 2,498 | 0 | 30,365 | 27.9 K to 30.4 K (+8.96 %) |
| Feb 09 2016 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | M | 0.00 | 3,194 | 0 | 0 | |
| Feb 09 2016 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Payment of Exercise | F | 250.77 | 1,047 | 262,556 | 24,404 | 25.5 K to 24.4 K (-4.11 %) |
| Feb 09 2016 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Buy | M | 0.00 | 3,194 | 0 | 25,451 | 22.3 K to 25.5 K (+14.35 %) |
| Feb 09 2016 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Option Exercise | M | 0.00 | 4,026 | 0 | 0 | |
| Feb 09 2016 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Payment of Exercise | F | 250.77 | 1,324 | 332,019 | 28,342 | 29.7 K to 28.3 K (-4.46 %) |
| Feb 09 2016 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Buy | M | 0.00 | 4,026 | 0 | 29,666 | 25.6 K to 29.7 K (+15.70 %) |
| Feb 09 2016 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Option Exercise | M | 0.00 | 2,709 | 0 | 0 | |
| Feb 09 2016 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Payment of Exercise | F | 250.77 | 890 | 223,185 | 6,140 | 7 K to 6.1 K (-12.66 %) |
| Feb 09 2016 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Buy | M | 0.00 | 2,709 | 0 | 7,030 | 4.3 K to 7 K (+62.69 %) |
| Feb 02 2016 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Option Exercise | M | 0.00 | 2,466 | 0 | 1 | |
| Feb 02 2016 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Payment of Exercise | F | 273.45 | 812 | 222,041 | 1,654 | 2.5 K to 1.7 K (-32.93 %) |
| Feb 02 2016 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Buy | M | 273.45 | 2,466 | 674,328 | 2,466 | 0 to 2.5 K |
| Dec 07 2015 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Sell | S | 277.00 | 441 | 122,157 | 7,740 | 8.2 K to 7.7 K (-5.39 %) |
| Dec 07 2015 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Payment of Exercise | F | 275.44 | 393 | 108,248 | 8,181 | 8.6 K to 8.2 K (-4.58 %) |
| Dec 03 2015 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech. and Bus. ... | Sell | S | 289.14 | 48 | 13,879 | 7,875 | 7.9 K to 7.9 K (-0.61 %) |
| Dec 03 2015 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech. and Bus. ... | Payment of Exercise | F | 290.04 | 171 | 49,597 | 7,923 | 8.1 K to 7.9 K (-2.11 %) |
| Dec 03 2015 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Grant | A | 0.00 | 483 | 0 | 2,244 | 1.8 K to 2.2 K (+27.43 %) |
| Oct 26 2015 | IDPH | BIOGEN INC. | DENNER ALEXANDER J | Director | Buy | P | 276.77 | 100,000 | 27,677,000 | 310,000 | 210 K to 310 K (+47.62 %) |
| Oct 26 2015 | IDPH | BIOGEN INC. | DENNER ALEXANDER J | Director | Buy | P | 277.80 | 210,000 | 58,338,000 | 210,000 | 0 to 210 K |
| Oct 06 2015 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech. and Bus. ... | Sell | S | 291.43 | 269 | 78,395 | 8,094 | 8.4 K to 8.1 K (-3.22 %) |
| Oct 05 2015 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech. and Bus. ... | Option Exercise | J | 0.00 | 2,323 | 0 | 8,528 | |
| Oct 05 2015 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech. and Bus. ... | Option Exercise | M | 0.00 | 1,939 | 0 | 10,851 | |
| Oct 05 2015 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech. and Bus. ... | Sell | S | 283.38 | 417 | 118,169 | 8,363 | 8.8 K to 8.4 K (-4.75 %) |
| Oct 05 2015 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech. and Bus. ... | Payment of Exercise | F | 287.30 | 862 | 247,653 | 8,780 | 9.6 K to 8.8 K (-8.94 %) |
| Oct 05 2015 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech. and Bus. ... | Payment of Exercise | F | 287.30 | 804 | 230,989 | 9,642 | 10.4 K to 9.6 K (-7.70 %) |
| Oct 05 2015 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech. and Bus. ... | Buy | M | 0.00 | 1,939 | 0 | 10,446 | 8.5 K to 10.4 K (+22.79 %) |
| Jul 27 2015 | IDPH | BIOGEN INC. | PAPADOPOULOS STELIOS | Director | Buy | P | 304.98 | 5,000 | 1,524,895 | 5,000 | 0 to 5 K |
| Jul 27 2015 | IDPH | BIOGEN INC. | PAPADOPOULOS STELIOS | Director | Buy | P | 304.78 | 5,000 | 1,523,880 | 5,000 | 0 to 5 K |
| Jun 23 2015 | IDPH | BIOGEN INC. | Posner Brian S | Director | Sell | S | 415.00 | 470 | 195,050 | 5,275 | 5.7 K to 5.3 K (-8.18 %) |
| Jun 22 2015 | IDPH | BIOGEN INC. | WILLIAMS DOUGLAS E | EVP Research & Deve ... | Sell | S | 410.00 | 3,841 | 1,574,810 | 11,817 | 15.7 K to 11.8 K (-24.53 %) |
| Jun 16 2015 | IDPH | BIOGEN INC. | Posner Brian S | Director | Sell | S | 386.64 | 400 | 154,656 | 5,745 | 6.1 K to 5.7 K (-6.51 %) |
| Jun 11 2015 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Grant | A | 0.00 | 695 | 0 | 4,845 | 4.2 K to 4.8 K (+16.75 %) |
| Jun 11 2015 | IDPH | BIOGEN INC. | PAPADOPOULOS STELIOS | Director | Grant | A | 0.00 | 1,040 | 0 | 16,580 | 15.5 K to 16.6 K (+6.69 %) |
| Jun 11 2015 | IDPH | BIOGEN INC. | Posner Brian S | Director | Grant | A | 0.00 | 695 | 0 | 6,145 | 5.5 K to 6.1 K (+12.75 %) |
| Jun 11 2015 | IDPH | BIOGEN INC. | SCHENK LYNN | Director | Grant | A | 0.00 | 695 | 0 | 4,890 | 4.2 K to 4.9 K (+16.57 %) |
| Jun 11 2015 | IDPH | BIOGEN INC. | Mulligan Richard | Director | Grant | A | 0.00 | 695 | 0 | 7,890 | 7.2 K to 7.9 K (+9.66 %) |
| Jun 11 2015 | IDPH | BIOGEN INC. | PANGIA ROBERT W | Director | Grant | A | 0.00 | 695 | 0 | 15,568 | 14.9 K to 15.6 K (+4.67 %) |
| Jun 11 2015 | IDPH | BIOGEN INC. | DORSA CAROLINE | Director | Grant | A | 0.00 | 695 | 0 | 16,033 | 15.3 K to 16 K (+4.53 %) |
| Jun 11 2015 | IDPH | BIOGEN INC. | DENNER ALEXANDER J | Director | Grant | A | 0.00 | 695 | 0 | 7,890 | 7.2 K to 7.9 K (+9.66 %) |
| Jun 11 2015 | IDPH | BIOGEN INC. | LEAMING NANCY | Director | Grant | A | 0.00 | 695 | 0 | 7,924 | 7.2 K to 7.9 K (+9.61 %) |
| Jun 11 2015 | IDPH | BIOGEN INC. | Rowinsky Eric K | Director | Grant | A | 0.00 | 695 | 0 | 12,005 | 11.3 K to 12 K (+6.15 %) |
| Jun 04 2015 | IDPH | BIOGEN INC. | Koppel Adam | SVP, Chief Strategy ... | Option Exercise | J | 0.00 | 1,228 | 0 | 7,228 | |
| Jun 04 2015 | IDPH | BIOGEN INC. | Koppel Adam | SVP, Chief Strategy ... | Option Exercise | M | 0.00 | 2,384 | 0 | 8,456 | |
| Jun 04 2015 | IDPH | BIOGEN INC. | Koppel Adam | SVP, Chief Strategy ... | Payment of Exercise | F | 387.62 | 852 | 330,252 | 1,662 | 2.5 K to 1.7 K (-33.89 %) |
| Jun 04 2015 | IDPH | BIOGEN INC. | Koppel Adam | SVP, Chief Strategy ... | Buy | M | 0.00 | 2,384 | 0 | 2,514 | 130 to 2.5 K (+1,833.85 %) |
| Jun 02 2015 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Sell | S | 398.87 | 1,362 | 543,261 | 41,090 | 42.5 K to 41.1 K (-3.21 %) |
| May 05 2015 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Option Exercise | M | 0.00 | 347 | 0 | 348 | |
| May 05 2015 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Payment of Exercise | F | 386.22 | 113 | 43,643 | 1,761 | 1.9 K to 1.8 K (-6.03 %) |
| May 05 2015 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Buy | M | 386.22 | 347 | 134,018 | 1,874 | 1.5 K to 1.9 K (+22.72 %) |
| May 05 2015 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Sell | S | 377.52 | 1,362 | 514,182 | 42,452 | 43.8 K to 42.5 K (-3.11 %) |
| Apr 03 2015 | IDPH | BIOGEN INC. | Artavanis-Tsakonas Spyridon | SVP, Chief Scientif ... | Option Exercise | M | 0.00 | 975 | 0 | 975 | |
| Apr 03 2015 | IDPH | BIOGEN INC. | Artavanis-Tsakonas Spyridon | SVP, Chief Scientif ... | Payment of Exercise | F | 412.44 | 460 | 189,722 | 1,674 | 2.1 K to 1.7 K (-21.56 %) |
| Apr 03 2015 | IDPH | BIOGEN INC. | Artavanis-Tsakonas Spyridon | SVP, Chief Scientif ... | Buy | M | 0.00 | 975 | 0 | 2,134 | 1.2 K to 2.1 K (+84.12 %) |
| Apr 02 2015 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Sell | S | 423.20 | 1,362 | 576,398 | 43,814 | 45.2 K to 43.8 K (-3.01 %) |
| Mar 30 2015 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Sell | S | 430.12 | 430 | 184,952 | 8,574 | 9 K to 8.6 K (-4.78 %) |
| Mar 26 2015 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Option Exercise | M | 60.56 | 2,891 | 175,079 | 2,892 | |
| Mar 26 2015 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Option Exercise | M | 72.87 | 2,175 | 158,492 | 0 | |
| Mar 26 2015 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Sell | S | 449.06 | 12,010 | 5,393,211 | 25,567 | 37.6 K to 25.6 K (-31.96 %) |
| Mar 26 2015 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Buy | M | 60.56 | 2,891 | 175,079 | 37,577 | 34.7 K to 37.6 K (+8.33 %) |
| Mar 26 2015 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Buy | M | 72.87 | 2,175 | 158,492 | 34,686 | 32.5 K to 34.7 K (+6.69 %) |
| Mar 23 2015 | IDPH | BIOGEN INC. | Rowinsky Eric K | Director | Option Exercise | M | 59.82 | 11,667 | 697,920 | 0 | |
| Mar 23 2015 | IDPH | BIOGEN INC. | Rowinsky Eric K | Director | Sell | S | 475.00 | 11,667 | 5,541,825 | 11,310 | 23 K to 11.3 K (-50.78 %) |
| Mar 23 2015 | IDPH | BIOGEN INC. | Rowinsky Eric K | Director | Buy | M | 59.82 | 11,667 | 697,920 | 22,977 | 11.3 K to 23 K (+103.16 %) |
| Mar 20 2015 | IDPH | BIOGEN INC. | Rowinsky Eric K | Director | Option Exercise | M | 59.82 | 2,333 | 139,560 | 11,667 | |
| Mar 20 2015 | IDPH | BIOGEN INC. | Rowinsky Eric K | Director | Sell | S | 436.14 | 2,333 | 1,017,508 | 11,310 | 13.6 K to 11.3 K (-17.10 %) |
| Mar 20 2015 | IDPH | BIOGEN INC. | Rowinsky Eric K | Director | Buy | M | 59.82 | 2,333 | 139,560 | 13,643 | 11.3 K to 13.6 K (+20.63 %) |
| Mar 18 2015 | IDPH | BIOGEN INC. | Rowinsky Eric K | Director | Option Exercise | M | 59.82 | 4,667 | 279,180 | 14,000 | |
| Mar 18 2015 | IDPH | BIOGEN INC. | Rowinsky Eric K | Director | Sell | S | 425.45 | 4,667 | 1,985,589 | 11,310 | 16 K to 11.3 K (-29.21 %) |
| Mar 18 2015 | IDPH | BIOGEN INC. | Rowinsky Eric K | Director | Buy | M | 59.82 | 4,667 | 279,180 | 15,977 | 11.3 K to 16 K (+41.26 %) |
| Mar 17 2015 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Sell | S | 415.46 | 803 | 333,614 | 0 | 803 to 0 (-100.00 %) |
| Mar 16 2015 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Sell | S | 412.69 | 537 | 221,613 | 45,176 | 45.7 K to 45.2 K (-1.17 %) |
| Mar 11 2015 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Option Exercise | M | 59.82 | 6,000 | 358,920 | 10,675 | |
| Mar 11 2015 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Sell | S | 409.67 | 6,000 | 2,458,020 | 4,150 | 10.2 K to 4.2 K (-59.11 %) |
| Mar 11 2015 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Buy | M | 59.82 | 6,000 | 358,920 | 10,150 | 4.2 K to 10.2 K (+144.58 %) |
| Mar 11 2015 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Gift | G | 0.00 | 275 | 0 | 4,150 | 4.4 K to 4.2 K (-6.21 %) |
| Mar 11 2015 | IDPH | BIOGEN INC. | Rowinsky Eric K | Director | Option Exercise | M | 59.82 | 4,666 | 279,120 | 18,667 | |
| Mar 11 2015 | IDPH | BIOGEN INC. | Rowinsky Eric K | Director | Sell | S | 417.23 | 4,666 | 1,946,795 | 11,310 | 16 K to 11.3 K (-29.21 %) |
| Mar 11 2015 | IDPH | BIOGEN INC. | Rowinsky Eric K | Director | Buy | M | 59.82 | 4,666 | 279,120 | 15,976 | 11.3 K to 16 K (+41.26 %) |
| Mar 11 2015 | IDPH | BIOGEN INC. | PANGIA ROBERT W | Director | Option Exercise | M | 52.22 | 500 | 26,110 | 5,450 | |
| Mar 11 2015 | IDPH | BIOGEN INC. | PANGIA ROBERT W | Director | Option Exercise | M | 46.99 | 3,125 | 146,844 | 0 | |
| Mar 11 2015 | IDPH | BIOGEN INC. | PANGIA ROBERT W | Director | Sell | S | 411.33 | 100 | 41,133 | 14,873 | 15 K to 14.9 K (-0.67 %) |
| Mar 11 2015 | IDPH | BIOGEN INC. | PANGIA ROBERT W | Director | Sell | S | 410.06 | 400 | 164,022 | 14,973 | 15.4 K to 15 K (-2.60 %) |
| Mar 11 2015 | IDPH | BIOGEN INC. | PANGIA ROBERT W | Director | Buy | M | 52.22 | 500 | 26,110 | 15,373 | 14.9 K to 15.4 K (+3.36 %) |
| Mar 11 2015 | IDPH | BIOGEN INC. | PANGIA ROBERT W | Director | Sell | S | 417.27 | 100 | 41,727 | 14,873 | 15 K to 14.9 K (-0.67 %) |
| Mar 11 2015 | IDPH | BIOGEN INC. | PANGIA ROBERT W | Director | Sell | S | 416.25 | 525 | 218,530 | 14,973 | 15.5 K to 15 K (-3.39 %) |
| Mar 11 2015 | IDPH | BIOGEN INC. | PANGIA ROBERT W | Director | Sell | S | 415.14 | 300 | 124,543 | 15,498 | 15.8 K to 15.5 K (-1.90 %) |
| Mar 11 2015 | IDPH | BIOGEN INC. | PANGIA ROBERT W | Director | Sell | S | 413.99 | 1,000 | 413,985 | 15,798 | 16.8 K to 15.8 K (-5.95 %) |
| Mar 11 2015 | IDPH | BIOGEN INC. | PANGIA ROBERT W | Director | Sell | S | 412.97 | 700 | 289,078 | 16,798 | 17.5 K to 16.8 K (-4.00 %) |
| Mar 11 2015 | IDPH | BIOGEN INC. | PANGIA ROBERT W | Director | Sell | S | 411.46 | 300 | 123,439 | 17,498 | 17.8 K to 17.5 K (-1.69 %) |
| Mar 11 2015 | IDPH | BIOGEN INC. | PANGIA ROBERT W | Director | Sell | S | 410.61 | 200 | 82,121 | 17,798 | 18 K to 17.8 K (-1.11 %) |
| Mar 11 2015 | IDPH | BIOGEN INC. | PANGIA ROBERT W | Director | Buy | M | 46.99 | 3,125 | 146,844 | 17,998 | 14.9 K to 18 K (+21.01 %) |
| Mar 03 2015 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Sell | S | 411.39 | 1,000 | 411,390 | 9,004 | 10 K to 9 K (-10.00 %) |
| Mar 03 2015 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Sell | S | 410.57 | 374 | 153,554 | 10,004 | 10.4 K to 10 K (-3.60 %) |
| Mar 03 2015 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Sell | S | 408.98 | 600 | 245,388 | 10,378 | 11 K to 10.4 K (-5.47 %) |
| Mar 03 2015 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Sell | S | 407.95 | 1,100 | 448,743 | 10,978 | 12.1 K to 11 K (-9.11 %) |
| Mar 03 2015 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Sell | S | 406.40 | 100 | 40,640 | 12,078 | 12.2 K to 12.1 K (-0.82 %) |
| Mar 03 2015 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Payment of Exercise | F | 409.59 | 2,826 | 1,157,501 | 12,178 | 15 K to 12.2 K (-18.83 %) |
| Mar 03 2015 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Sell | S | 410.67 | 825 | 338,803 | 45,713 | 46.5 K to 45.7 K (-1.77 %) |
| Feb 25 2015 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Option Exercise | A | 0.00 | 26,550 | 0 | 26,550 | |
| Feb 25 2015 | IDPH | BIOGEN INC. | Kingsley Stuart A | EVP, Global Comm. O ... | Option Exercise | A | 0.00 | 6,220 | 0 | 6,220 | |
| Feb 25 2015 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Option Exercise | A | 0.00 | 7,260 | 0 | 7,260 | |
| Feb 25 2015 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Option Exercise | A | 0.00 | 3,110 | 0 | 3,110 | |
| Feb 25 2015 | IDPH | BIOGEN INC. | Artavanis-Tsakonas Spyridon | SVP, Chief Scientif ... | Option Exercise | A | 0.00 | 1,300 | 0 | 1,300 | |
| Feb 25 2015 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | A | 0.00 | 5,190 | 0 | 5,190 | |
| Feb 25 2015 | IDPH | BIOGEN INC. | WILLIAMS DOUGLAS E | EVP Research & Deve ... | Option Exercise | A | 0.00 | 8,300 | 0 | 8,300 | |
| Feb 25 2015 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech. and Bus. ... | Option Exercise | A | 0.00 | 4,460 | 0 | 4,460 | |
| Feb 25 2015 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Option Exercise | A | 0.00 | 5,190 | 0 | 5,190 | |
| Feb 25 2015 | IDPH | BIOGEN INC. | Koppel Adam | SVP, Chief Strategy ... | Option Exercise | A | 0.00 | 2,700 | 0 | 2,700 | |
| Feb 25 2015 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Option Exercise | A | 0.00 | 5,700 | 0 | 5,700 | |
| Feb 25 2015 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Option Exercise | A | 0.00 | 600 | 0 | 600 | |
| Feb 25 2015 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Option Exercise | A | 0.00 | 5,700 | 0 | 5,700 | |
| Feb 20 2015 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Sell | S | 401.04 | 537 | 215,358 | 46,538 | 47.1 K to 46.5 K (-1.14 %) |
| Feb 18 2015 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Sell | S | 389.11 | 825 | 321,016 | 47,075 | 47.9 K to 47.1 K (-1.72 %) |
| Feb 18 2015 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Sell | S | 389.11 | 2,128 | 828,026 | 4,321 | 6.4 K to 4.3 K (-33.00 %) |
| Feb 18 2015 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Sell | S | 389.11 | 418 | 162,648 | 15,004 | 15.4 K to 15 K (-2.71 %) |
| Feb 18 2015 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Sell | S | 389.11 | 1,188 | 462,263 | 803 | 2 K to 803 (-59.67 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Option Exercise | J | 0.00 | 4,093 | 0 | 20,996 | |
| Feb 17 2015 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Option Exercise | M | 0.00 | 6,401 | 0 | 25,089 | |
| Feb 17 2015 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Option Exercise | M | 0.00 | 9,198 | 0 | 18,371 | |
| Feb 17 2015 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Payment of Exercise | F | 392.11 | 4,781 | 1,874,678 | 47,900 | 52.7 K to 47.9 K (-9.08 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Grant | A | 0.00 | 10,149 | 0 | 52,681 | 42.5 K to 52.7 K (+23.86 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Payment of Exercise | F | 392.11 | 3,015 | 1,182,212 | 42,532 | 45.5 K to 42.5 K (-6.62 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Buy | M | 0.00 | 6,401 | 0 | 45,547 | 39.1 K to 45.5 K (+16.35 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Payment of Exercise | F | 392.11 | 4,329 | 1,697,444 | 39,146 | 43.5 K to 39.1 K (-9.96 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Buy | M | 0.00 | 9,198 | 0 | 43,475 | 34.3 K to 43.5 K (+26.83 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Option Exercise | J | 0.00 | 100 | 0 | 514 | |
| Feb 17 2015 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Option Exercise | M | 0.00 | 156 | 0 | 614 | |
| Feb 17 2015 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Option Exercise | M | 0.00 | 315 | 0 | 630 | |
| Feb 17 2015 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Payment of Exercise | F | 392.11 | 4 | 1,568 | 1,446 | 1.5 K to 1.4 K (-0.28 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Buy | M | 0.00 | 156 | 0 | 1,450 | 1.3 K to 1.5 K (+12.06 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Payment of Exercise | F | 392.11 | 16 | 6,274 | 1,294 | 1.3 K to 1.3 K (-1.22 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Buy | M | 0.00 | 315 | 0 | 1,310 | 995 to 1.3 K (+31.66 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Option Exercise | J | 0.00 | 954 | 0 | 4,894 | |
| Feb 17 2015 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Option Exercise | M | 0.00 | 1,492 | 0 | 5,848 | |
| Feb 17 2015 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Option Exercise | M | 0.00 | 2,142 | 0 | 4,289 |